IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 348.2 INR 1.89% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
IOL Chemicals and Pharmaceuticals Ltd?
Write Note

IOL Chemicals and Pharmaceuticals Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IOL Chemicals and Pharmaceuticals Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Interest Income Expense
-â‚ą143m
CAGR 3-Years
-35%
CAGR 5-Years
20%
CAGR 10-Years
13%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Interest Income Expense
-â‚ą1.8B
CAGR 3-Years
-70%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Interest Income Expense
-â‚ą810.4m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Interest Income Expense
â‚ą92m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Interest Income Expense
-â‚ą3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Interest Income Expense
â‚ą1.4B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
20.4B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
528.04 INR
Undervaluation 34%
Intrinsic Value
Price

See Also

What is IOL Chemicals and Pharmaceuticals Ltd's Interest Income Expense?
Interest Income Expense
-143m INR

Based on the financial report for Jun 30, 2024, IOL Chemicals and Pharmaceuticals Ltd's Interest Income Expense amounts to -143m INR.

What is IOL Chemicals and Pharmaceuticals Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
13%

Over the last year, the Interest Income Expense growth was 16%. The average annual Interest Income Expense growth rates for IOL Chemicals and Pharmaceuticals Ltd have been -35% over the past three years , 20% over the past five years , and 13% over the past ten years .

Back to Top